loader
CHANDAN HEALTHCARE LIMITED SME IPO
Issue Size (Net)
up to Rs.107.36 Cr
Price Band
Rs.151 to Rs.159 per share
Issue Opens
February 10, 2025
Issue Closes
February 12, 2025

Company Highlights

1.Company Information

Chandan Healthcare Limited was founded in September 2003 and operates diagnostic facilities in North India that provide radiology and pathology testing services. As of December 31, 2024, the company has over three hundred collecting centers spread over more than 23 cities in Uttar Pradesh and more than 19 in Uttarakhand, in addition to one flagship laboratory, seven central laboratories, and 26 satellite centers. The company offers 1,496 examinations in various specialties as of December 31, 2024. The test menu consists of There are 545 radiological tests, such as x-rays, ultrasound, CT, MRI, and specialized CT scans, 1,015 specialized tests, such as immunohistopathology and molecular pathology, and 481 standard pathology tests in basic biochemistry and haematology. There are four MRI machines and eleven CT scanners in the radiology facilities. 15 radiologists were employed by the organization as of December 31, 2024.

2. Strenghts

1) A provider of integrated diagnostics that provides imaging, pathology, and medical consultations.
2) A history of steady financial success and profitability.
3) A committed management group with a wealth of industry knowledge.
4) Uttarakhand has a significant geographic presence, with 39 tier-two cities and towns.

3. Objects of the Issue

The company proposes to utilize the Net Proceeds from the Offer towards the following objects:
1)Setting up a new Flagship Diagnostic Centre in Jankipuram, Lucknow, Uttar Pradesh.
2) Setting up a new Central Reference laboratory at Ayodhya, Uttar Pradesh
3) Setting up a new Central Reference laboratory at Ashiyana, Lucknow, Uttar Pradesh.
4) General corporate purposes.

4.CHANDAN HEALTHCARE LIMITED IPO Registrar
Kfin Technologies Limited

Phone: 04067162222, 04079611000
Email: chl.ipo@kfintech.com
Website: https://kosmic.kfintech.com

CHANDAN HEALTHCARE LIMITED IPO Financials

Period Ended
Total Assets
Total Revenue
Profit After Tax
Net Worth
Reserves and Surplus
Total Borrowing
30-Dec-24
170.06
167.99
17.42
34.31
51.92
31-Mar-24
128.86
177.96
16.36
41.09
21.16
42.01
31-Mar-23
97.83
137.03
3.59
27.30
7.37
21.36
31-Mar-22
81.23
119.92
-1.09
23.93
4.00
16.58
Amount in Rs. Lakhs

CHANDAN HEALTHCARE LIMITED IPO Details

Issue Opening Date
February 10, 2025
Issue Closing Date
February 12, 2025
Face Value
Rs.10 per share
Price
Rs.151 to Rs.159 per share
Lot Size
800 Shares
Issue Size
67,52,000 shares (aggregating up to Rs.107.36 Cr)
Fresh Issue
44,52,064 shares (aggregating up toRs. 70.79 Cr)
Issue Type
Book Built Issue IPO
Listing At
NSE SME

CHANDAN HEALTHCARE LIMITED IPO Timeline

Event
Tentative Date
Opening Date
Monday, February 10, 2025
Closing Date
Wednesday, February 12, 2025
Basis of Allotment
Thursday, February 13, 2025
Initiation of Refunds
Friday, February 14, 2025
Credit of Shares to Demat
Friday, February 14, 2025
Listing Date
Monday, February 17, 2025
Cut-off time for UPI mandate confirmation
5 PM on February 12, 2025

Prospectus

Prospectus File

RR Investors Capital Services Pvt. Ltd AMFI-registered Mutual Fund Distributor

ARN-0032 Validity 14-Mar-2027

Head Office - 4th floor, Indraprakash Building 21, Barakhamba Road, New Delhi – 110001

callLandline Number
+91 11-4444-1111

Customer Care
+91 9350316010

Security
  • SSL
Follow Us

SEBI Registration No: NSE Cash: INB231219636 | SEBI Registration No: NSE Derivative: INF231219636 | SEBI Registration No: BSE Cash: INB011219632 | SEBI Registration No: MCX-SX: INE261219636 | SEBI Registration No: NSE Currency: INE231219636 | SEBI Registration No: USE: INE271219631 | SEBI Registration No: CDSL: IN-DP-CDSL-3242005 | NCDEX Membership No: 00635 | MCX Membership No: 28850 | NSEL Membership No: 10650 | RBI Registration No: NBFC: N-14.03215 | IRDA Registration Number : CB-066/03 | AMFI Registration No : ARN -0032| SEBI Registration No: Merchant Banker: INM000007508


* Mutual fund investments are subject to market risks. Please read the scheme information and other related documents carefully before investing.


© 2022 RR Investors Capital Services Pvt. Ltd | All Rights Reserved.